Recent Progress of Lipid Nanoparticles-Based Lipophilic Drug Delivery: Focus on Surface Modifications
Pharmaceutics · 26.02.2023 · 15 (3) · 772
DOI: 10.3390/pharmaceutics15030772 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Pharmaceutics, online erschienen am 26.02.2023. Verfasst von Yoseph Seo und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemical Engineering, Kwangwoon University, 20 Kwangwoon-Ro, Nowon-Gu, Seoul 01897, Republic of Korea. Die Arbeit wurde bisher 125-mal zitiert (Crossref) und nennt 179 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Korea Ministry of Environment (MOE), Ministry of Trade, Industry and Energy (MOTIE, Korea).
Abstract (Originalsprache)
Numerous drugs have emerged to treat various diseases, such as COVID-19, cancer, and protect human health. Approximately 40% of them are lipophilic and are used for treating diseases through various delivery routes, including skin absorption, oral administration, and injection. However, as lipophilic drugs have a low solubility in the human body, drug delivery systems (DDSs) are being actively developed to increase drug bioavailability. Liposomes, micro-sponges, and polymer-based nanoparticles have been proposed as DDS carriers for lipophilic drugs. However, their instability, cytotoxicity, and lack of targeting ability limit their commercialization. Lipid nanoparticles (LNPs) have fewer side effects, excellent biocompatibility, and high physical stability. LNPs are considered efficient vehicles of lipophilic drugs owing to their lipid-based internal structure. In addition, recent LNP studies suggest that the bioavailability of LNP can be increased through surface modifications, such as PEGylation, chitosan, and surfactant protein coating. Thus, their combinations have an abundant utilization potential in the fields of DDSs for carrying lipophilic drugs. In this review, the functions and efficiencies of various types of LNPs and surface modifications developed to optimize lipophilic drug delivery are discussed.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Chemical Engineering, Kwangwoon University, 20 Kwangwoon-Ro, Nowon-Gu, Seoul 01897, Republic of Korea.
- Department of Biotechnology, Sangmyung University, 20, Hongjimun 2-Gil, Jongno-Gu, Seoul 03016, Republic of Korea.
ORCID-Profile: Hyunjun Park, Hah Young Yoo
Förderung
- Korea Ministry of Environment (MOE)
- Ministry of Trade, Industry and Energy (MOTIE, Korea)
Zitieren
APA
Seo, Y., Lim, H., Park, H., Yu, J., An, J., Yoo, H. Y., & Lee, T. (2023). Recent Progress of Lipid Nanoparticles-Based Lipophilic Drug Delivery: Focus on Surface Modifications. Pharmaceutics, 15(3), 772. https://doi.org/10.3390/pharmaceutics15030772
Vancouver
Seo Y, Lim H, Park H, Yu J, An J, Yoo HY, et al. Recent Progress of Lipid Nanoparticles-Based Lipophilic Drug Delivery: Focus on Surface Modifications. Pharmaceutics. 2023;15(3):772. doi:10.3390/pharmaceutics15030772
BibTeX
@article{Seo2023,
author = {Seo, Yoseph and Lim, Hayeon and Park, Hyunjun and Yu, Jiyun and An, Jeongyun and Yoo, Hah Young and Lee, Taek},
title = {Recent Progress of Lipid Nanoparticles-Based Lipophilic Drug Delivery: Focus on Surface Modifications},
journal = {Pharmaceutics},
year = {2023},
volume = {15},
number = {3},
pages = {772},
doi = {10.3390/pharmaceutics15030772}
}
EUVIMED